Having trouble viewing this email? View in your browser.

24 May 2016

Dear colleagues,

Gunnar Kahlmeter explains the role of EUCAST’s antimicrobial susceptibility breakpoints for the fight against resistance in an article in Pharmtech. Other publications of interest are the UK’s review on Antimicrobial Resistance where the final report outlines the issues and recommendations. And the European Medicines Agency also published its 2015 annual report, which focuses on the agency’s core tasks: evaluation of medicines, support to R&D of new treatments and monitoring of benefits and risks of medicines.

Best regards, your ESCMID communications editors

ESCMID Executive Office
Gerbergasse 14
4001 Basel
Phone +41 61 508 0150
Visit us on mastodon Visit us on LinkedIn Visit us on YouTube
The ESCMID Newsletter is issued on behalf of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) by the ESCMID Executive Office. It contains announcements of ESCMID-related matters and other information of interest to professionals in the infection field.

Tip: To ensure that you receive the ESCMID newsletter in your inbox, add newsletter@escmid.org to your email program’s address book.

You have received this email as a contact of ESCMID or one of its affiliated societies. You can unsubscribe or change your newsletter subscriptions here.